ASX:LBT

LBT Innovations (LBT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
857,080 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.81%
Price Target
N/A
LBT stock logo

About LBT Innovations Stock (ASX:LBT)

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

LBT Stock News Headlines

Is LBT Innovations (ASX:LBT) Weighed On By Its Debt Load?
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
AKVA group ASA: Q1 2022 financial reporting
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Does LBT Innovations (ASX:LBT) Have A Healthy Balance Sheet?
See More Headlines
Receive LBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LBT Innovations and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2019
Today
5/06/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
$-21,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.98 million

Miscellaneous

Outstanding Shares
1,340,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.36
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Brenton John Barnes
    CEO, MD & Director
  • Mr. Raymond Robert Ridge B.A.
    BA (Acc), C.A., CA, GIA (cert), CFO, Company Secretary & Director
  • Dr. Steven Giglio
    Scientific Director
  • Mr. Jack Brown
    Corporate Development Director

LBT Stock Analysis - Frequently Asked Questions

How were LBT Innovations' earnings last quarter?

LBT Innovations Limited (ASX:LBT) posted its quarterly earnings results on Tuesday, February, 26th. The company reported ($0.01) earnings per share for the quarter.

This page (ASX:LBT) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners